2025 annual financial data
Capricor Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -108,142,130 USD and net income was -105,043,946 USD.
Operating cash flow was -69,811,261 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -108,142,130 USD
- Net income
- -105,043,946 USD
- Operating cash flow
- -69,811,261 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Capricor Therapeutics financial years